atorvastatin has been researched along with Abdominal Obesity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogucki, J; Feldo, J; Feldo, M; Kęsik, J; Kocki, J; Lukasik, S; Terlecki, P; Wroński, J; Zubilewicz, T | 1 |
| Ballantyne, CM; Hsueh, WA; Lin, J; Lowe, RS; Rosen, JB; Shah, AK; Tershakovec, AM | 1 |
| Barrett, PH; Chan, DC; Nguyen, MN; Ooi, EM; Watts, GF | 1 |
| Byrne, CD; Chipperfield, AJ; Clough, GF; Gamble, J; Krentz, AJ; L'Esperance, V; Turzyniecka, M; Walter, L | 1 |
3 trial(s) available for atorvastatin and Abdominal Obesity
| Article | Year |
|---|---|
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Blood Glucose; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Ezetimibe; Female; Humans; Hypercholesterolemia; Insulin Resistance; Lipoproteins, HDL; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Risk Factors; Simvastatin; Treatment Outcome; Triglycerides | 2015 |
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesity.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein C-III; Atorvastatin; Cholesterol, VLDL; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Heptanoic Acids; Humans; Male; Middle Aged; Obesity, Abdominal; Pyrroles; Triglycerides | 2010 |
Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment.
Topics: Acute Disease; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Flow Velocity; Female; Heptanoic Acids; Humans; Hyperemia; Hyperinsulinism; Insulin Resistance; Male; Microcirculation; Middle Aged; Obesity, Abdominal; Pyrroles; Risk Factors; Vasodilation | 2011 |
1 other study(ies) available for atorvastatin and Abdominal Obesity
| Article | Year |
|---|---|
CIDE--A gene expression in patients with abdominal obesity and LDL hyperlipoproteinemia qualified for surgical revascularization in chronic limb ischemia.
Topics: Aged; Apoptosis Regulatory Proteins; Atorvastatin; Body Mass Index; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Humans; Hyperlipoproteinemias; Ischemia; Leg; Lipoproteins, LDL; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal | 2013 |